Acquired Company
BridgeBio completed its acquisition of all outstanding shares of Eidos Therapeutics, Inc. on January 26, 2021.
Show more
101 Montgomery St Ste 2550, California, 94104-4158, US
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$122.21
Open
$122.21
Volume
N/A
Day Range
$122.21 - $122.21
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
06/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|